Yesterday, the Federal Circuit granted Teva’s petition for en banc rehearing.1 The Court ordered the October 2, 2020 judgment reversing the JMOL and remanding for entry of the jury verdict judgment vacated and the October 2, 2020 opinions withdrawn.2 The panel will rehear the appeals on the merits.3
The en banc oral argument is set for February 23, 2021.4 The Court stated the oral argument will be limited to the following issue raised in Teva’s petition for en banc rehearing: “whether there is substantial evidence to support the jury’s verdict of induced infringement during the time period from January 8, 2008 through April 30, 2011,” finding “all other issues to be sufficiently briefed.”5
We will provide an update following the February 23 oral argument. Please contact the authors with any questions and stay tuned for updates regarding this important topic.
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.